Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1906 AL 1920

Ambient temperature and nervous system diseases-related mortality in Japan from 2010 to 2019: A time-stratified case-crossover analysis

Lin SY, Ng CFS, Kim Y, Htay ZW, Cao AQ, Pan R, Hashizume M.

Sci Total Environ. 2023 Apr 1;867:161464. doi: 10.1016/j.scitotenv.2023.161464. Epub 2023 Jan 6.

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer's Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil

Killick R, Elliott C, Ribe E, Broadstock M, Ballard C, Aarsland D, Williams G.

Int J Mol Sci. 2023 Jul 7;24(13):11219. doi: 10.3390/ijms241311219.

The Role of Sesamin in Targeting Neurodegenerative Disorders: A Systematic Review

Ghaderi MA, Emami SA, Beirak Olia MD, Javadi B.

Mini Rev Med Chem. 2023;23(6):756-770. doi: 10.2174/1389557522666220523112027.

A New Hope in Alzheimer's Disease Psychosis: Pimavanserin

Kurhan F, Akın M.

Curr Alzheimer Res. 2023;20(6):403-408. doi: 10.2174/1567205020666230825124922.

Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial

Fernandez HH, Weintraub D, Macklin E, Litvan I, Schwarzschild MA, Eberling J, Videnovic A, Kenney CJ; Parkinson Study Group SYNAPSE Investigators.

Parkinsonism Relat Disord. 2023 Sep;114:105511. doi: 10.1016/j.parkreldis.2023.105511. Epub 2023 Jul 13.

Wrist-worn sensor-based measurements for drug effect detection with small samples in people with Lewy Body Dementia

Chen C, Kowahl NR, Rainaldi E, Burq M, Munsie LM, Battioui C, Wang J, Biglan K, Marks WJ Jr, Kapur R.

Parkinsonism Relat Disord. 2023 Apr;109:105355. doi: 10.1016/j.parkreldis.2023.105355. Epub 2023 Mar 4.

SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses

Smadi M, Kaburis M, Schnapper Y, Reina G, Molero P, Molendijk ML.

Br J Psychiatry. 2023 Aug;223(2):348-361. doi: 10.1192/bjp.2023.43.

Association between animal protein sources and risk of neurodegenerative diseases: a systematic review and dose-response meta-analysis

Talebi S, Asoudeh F, Naeini F, Sadeghi E, Travica N, Mohammadi H.

Nutr Rev. 2023 Aug 10;81(9):1131-1143. doi: 10.1093/nutrit/nuac114.

Global ambient particulate matter pollution and neurodegenerative disorders: a systematic review of literature and meta-analysis

Gong Y, Zhang X, Zhao X, Chang H, Zhang J, Gao Z, Mi Y, Chen Y, Zhang H, Huang C, Yu Z.

Environ Sci Pollut Res Int. 2023 Mar;30(14):39418-39430. doi: 10.1007/s11356-023-25731-0. Epub 2023 Feb 10.

Uric acid levels and their association with vascular dementia and Parkinson's disease dementia: a meta-analysis

Li Q, Cen K, Cui Y, Feng X, Hou X.

Neurol Sci. 2023 Jun;44(6):2017-2024. doi: 10.1007/s10072-023-06620-3. Epub 2023 Jan 24.

New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis

Rahmati M, Yon DK, Lee SW, Soysal P, Koyanagi A, Jacob L, Li Y, Park JM, Kim YW, Shin JI, Smith L.

J Med Virol. 2023 Jul;95(7):e28909. doi: 10.1002/jmv.28909.

Genome-Wide Meta-Analysis of Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Parkinson's Disease Cohorts

Ta M, Blauwendraat C, Antar T, Leonard HL, Singleton AB, Nalls MA, Iwaki H; Alzheimer's Disease Neuroimaging Initiative (ADNI); and the Fox Investigation for New Discovery of Biomarkers.

Mov Disord. 2023 Sep;38(9):1697-1705. doi: 10.1002/mds.29511. Epub 2023 Aug 4.

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis

Bittner N, Funk CSM, Schmidt A, Bermpohl F, Brandl EJ, Algharably EEA, Kreutz R, Riemer TG.

Drugs Aging. 2023 Nov;40(11):953-964. doi: 10.1007/s40266-023-01065-x. Epub 2023 Sep 8.

Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients

Fang C, Hernandez P, Liow K, Damiano E, Zetterberg H, Blennow K, Feng D, Chen M, Maccecchini M.

J Prev Alzheimers Dis. 2023;10(1):25-33. doi: 10.14283/jpad.2022.84.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias